Levocarnitine has been used in the treatment of primary and secondary carnitine deficiency in adults and neonates, Alzheimers disease, dilated cardiomyopathy in adults and children, valproic acid-induced hepatotoxicity in children, and hyperlipoproteinemia
A 2015 study showed that intra-articular AOD-9604 injections, especially when combined with hyaluronic acid, significantly improved cartilage healing in an animal model of osteoarthritis Future Development Researchers are exploring: Alternative delivery systems (e.g., oral, transdermal) Higher-dose protocols for chronic joint issues Combination peptide therapies for compounded metabolic and regenerative effects As peptide science evolves, AOD-9604 may become a foundational tool in the management of obesity, metabolic dysfunction, and degenerative joint diseases
Once you complete the recommended number of sessions, while following proper post-care, you can be assured of the results that last for several months
Thymosin alpha-1 and KPV have the most direct evidence for autoimmune applications
